Who
Robert I. Blum
President & CEO
Company insider
Files Form 4 as: President & CEO, Cytokinetics; Director, Gamida Cell.
In numbers
- Trades disclosed
- 856
- Buys
- 1
- Sells
- 232
- Bought
- $78K
- Sold
- $78.7M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 15 Feb 2006
- Last trade
- 12 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 13 Oct 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $80K7,500 at $10.60 | filing |
| 12 Oct 2026filed 13 Oct 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $472K7,500 at $62.88 | filing |
| 12 Oct 2026filed 13 Oct 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 28 Sep 2026filed 28 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $80K7,500 at $10.60 | filing |
| 28 Sep 2026filed 28 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $491K7,500 at $65.46 | filing |
| 28 Sep 2026filed 28 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 28 Sep 2026filed 28 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 28 Sep 2026filed 28 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $80K7,500 at $10.60 | filing |
| 28 Sep 2026filed 28 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $491K7,500 at $65.46 | filing |
| 15 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $6.8M97,926 at $69.33 | filing |
| 15 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $6.8M97,926 at $69.33 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $80K7,500 at $10.60 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $551K7,500 at $73.44 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code G | —1,350 at $0.00 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code G | —97,926 at $0.00 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code G | —97,926 at $0.00 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $80K7,500 at $10.60 | filing |
| 14 Sep 2026filed 15 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $551K7,500 at $73.44 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Analyzing Inhibrx Biosciences (NASDAQ:INBX) and Cytokinetics (NASDAQ:CYTK)CYTK · themarketsdaily.com · 25 Oct 2026Head to Head Survey: Maze Therapeutics (NASDAQ:MAZE) vs. Cytokinetics (NASDAQ:CYTK)CYTK · dailypolitical.com · 18 Oct 2026Contrasting Gain Therapeutics (NASDAQ:GANX) and Cytokinetics (NASDAQ:CYTK)CYTK · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Robert I. Blum; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.